ConductScience.org, home

Paper39776249

Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.

Rabinovici GD and 15 others. Alzheimers Dement, 2025. Cited by 127 papers, by iCite.

Cite this record

ConductScience Library. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Papers, record 39776249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39776249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.
PubMed
Journal
Alzheimers Dement
PubMed
Year
2025
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
127
iCite
Relative citation ratio, by iCite
37.73, provisional
iCite
Revised in PubMed
2026-05-18
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rabinovici GDGil Dhttps://orcid.org/0000-0002-3626-4265
2Knopman DSDavid S
3Arbizu JJavier
4Benzinger TLSTammie L S
5Donohoe KJKevin J
6Hansson OOskar
7Herscovitch PPeter
8Kuo PHPhillip H
9Lingler JHJennifer H
10Minoshima SSatoshi
11Murray MEMelissa E
12Price JCJulie C
13Salloway SPStephen P
14Weber CJChristopher J
15Carrillo MCMaria C
16Johnson KAKeith A

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
AmyloidMajor topic
BrainMajor topic
Molecular ImagingMajor topic
Positron-Emission TomographyMajor topic
tau ProteinsMajor topic
Humans
Nuclear Medicine
Societies, Medical

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in40105389Beyond the AJR: Updated Guidelines on the Appropriate Use of Amyloid and Tau PET in Clinical Practice.https://conductscience.org/library/papers/40105389

Source PubMed

Download CSV of comments and corrections

References248

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128592453Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.Neurology2017https://conductscience.org/library/papers/28592453PubMed
229050382Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.Brain2017https://conductscience.org/library/papers/29050382PubMed
325824567Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.Alzheimers Dement2015https://conductscience.org/library/papers/25824567PubMed
431371569High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.Neurology2019https://conductscience.org/library/papers/31371569PubMed
530938796Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.JAMA2019https://conductscience.org/library/papers/30938796PubMed
633585983Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.Acta Neuropathol2021https://conductscience.org/library/papers/33585983PubMed
734083813Biomarkers for neurodegenerative diseases.Nat Med2021https://conductscience.org/library/papers/34083813PubMed
838048096Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.JAMA Neurol2024https://conductscience.org/library/papers/38048096PubMed
929653606NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement2018https://conductscience.org/library/papers/29653606PubMed
1029114726Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.JAMA Neurol2017https://conductscience.org/library/papers/29114726PubMed
1139776249Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.Alzheimers Dement2025https://conductscience.org/library/papers/39776249PubMed
1229499171CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.Alzheimers Dement2018https://conductscience.org/library/papers/29499171PubMed
1322749065Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.Lancet Neurol2012https://conductscience.org/library/papers/22749065PubMed
1430326496Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.JAMA2018https://conductscience.org/library/papers/30326496PubMed
1529049582Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.JAMA2017https://conductscience.org/library/papers/29049582PubMed
1623166389Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.J Nucl Med2013https://conductscience.org/library/papers/23166389PubMed
1734279544Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis.JAMA Neurol2021https://conductscience.org/library/papers/34279544PubMed
1837421950Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies.Cell2023https://conductscience.org/library/papers/37421950PubMed
1928259709Consensus classification of posterior cortical atrophy.Alzheimers Dement2017https://conductscience.org/library/papers/28259709PubMed
2024798886A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.Alzheimers Dement2014https://conductscience.org/library/papers/24798886PubMed

See all 248 referencesDownload CSV of references

Cited by100

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.

PMIDTitleJournalYearIn PapersSource
42880054Updated Italian intersocietal recommendations for the appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease.J Prev Alzheimers Dis2026https://conductscience.org/library/papers/42880054PubMed
42877686Low-dose CT for MRI-free quantification of tau PET in Alzheimer's disease: a multicentre, cross-sectional, comparison study.Lancet Med Imaging Theranostics2026https://conductscience.org/library/papers/42877686PubMed
42877495Current use and perspectives of PET imaging in Alzheimer's disease: A Spanish national survey.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877495PubMed
42769842Exercise timing as a potential temporal regulator of neurolymphatic physiology in neurodegenerative proteinopathies: a mechanistic framework.Front Neurosci2026https://conductscience.org/library/papers/42769842PubMed
42760345Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.Nat Rev Neurol2026https://conductscience.org/library/papers/42760345PubMed
42742914From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease.CNS Drugs2026https://conductscience.org/library/papers/42742914PubMed
42720909Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring.Mol Diagn Ther2026https://conductscience.org/library/papers/42720909PubMed
42683384From amyloid PET to plasma biomarkers: A multimodal imaging framework for early diagnosis and staging of Alzheimer's disease.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42683384PubMed
42661000Prognostic value of Amyloid PET in Real-World Amnestic MCI: Influence of reader experience and interpretation method.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42661000PubMed
42643714Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease.Front Neurol2026https://conductscience.org/library/papers/42643714PubMed
42597430Medical comorbidities of patients receiving amyloid-targeting treatments in a memory clinic.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42597430PubMed
42565262Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.Alzheimers Dement2026https://conductscience.org/library/papers/42565262PubMed
42535261Exploring longitudinal relationships among Alzheimer's disease biomarkers.Alzheimers Dement2026https://conductscience.org/library/papers/42535261PubMed
42533677Classification of tau status with machine learning models in amyloid-positive cohorts.Alzheimers Dement2026https://conductscience.org/library/papers/42533677PubMed
42507054Serial amyloid PET demonstrates marked reduction in amyloid burden following donanemab treatment: a real-world cohort study.Jpn J Radiol2026https://conductscience.org/library/papers/42507054PubMed
42505444Research Advances in Diagnostic Methods for Prevalent Neurological Diseases.Biosensors (Basel)2026https://conductscience.org/library/papers/42505444PubMed
4246718218F-flortaucipir PET imaging: Biodistribution in the Japanese population and diagnostic accuracy by Japanese readers.Ann Nucl Med2026https://conductscience.org/library/papers/42467182PubMed
42458104Tau-mediated Mechanisms in Alzheimer's Disease Pathogenesis.Mol Neurobiol2026https://conductscience.org/library/papers/42458104PubMed
42453713Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment.AIMS Neurosci2026https://conductscience.org/library/papers/42453713PubMed
42436578A probabilistic framework for clinicopathological Alzheimer's disease using tau-PET.Alzheimers Res Ther2026https://conductscience.org/library/papers/42436578PubMed

See all 100 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39776249

GET https://conductscience.org/api/papers/v1/39776249/references?page=2